Flossbach Von Storch AG lessened its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 6.8% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 43,010 shares of the medical research company’s stock after selling 3,150 shares during the period. Flossbach Von Storch AG’s holdings in Thermo Fisher Scientific were worth $8,137,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the company. Amalgamated Bank grew its holdings in Thermo Fisher Scientific by 57.0% during the 2nd quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock valued at $7,837,000 after buying an additional 16,308 shares in the last quarter. Mutual of America Capital Management LLC grew its holdings in Thermo Fisher Scientific by 2.1% during the 2nd quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock valued at $8,327,000 after buying an additional 977 shares in the last quarter. Mitchell Capital Management Co. grew its holdings in Thermo Fisher Scientific by 40.3% during the 2nd quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock valued at $7,841,000 after buying an additional 12,910 shares in the last quarter. State Board of Administration of Florida Retirement System grew its holdings in Thermo Fisher Scientific by 0.9% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock valued at $101,317,000 after buying an additional 5,213 shares in the last quarter. Finally, San Francisco Sentry Investment Group CA purchased a new stake in Thermo Fisher Scientific during the 2nd quarter valued at approximately $1,451,000. Hedge funds and other institutional investors own 86.16% of the company’s stock.
Thermo Fisher Scientific Inc. (NYSE TMO) traded up $1.53 during mid-day trading on Tuesday, hitting $189.49. 1,423,700 shares of the company were exchanged, compared to its average volume of 1,564,405. Thermo Fisher Scientific Inc. has a 1 year low of $139.88 and a 1 year high of $201.20. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. The stock has a market capitalization of $75,371.09, a price-to-earnings ratio of 20.66, a PEG ratio of 1.72 and a beta of 1.06.
Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same period last year, the firm posted $2.03 earnings per share. Thermo Fisher Scientific’s revenue for the quarter was up 13.9% compared to the same quarter last year. research analysts anticipate that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.
A number of equities research analysts have issued reports on the stock. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, September 18th. Barclays reaffirmed an “overweight” rating and set a $215.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. Argus reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Jefferies Group reaffirmed a “hold” rating and set a $195.00 price objective on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. One investment analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $205.21.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the completion of the transaction, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.49% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: This story was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://ledgergazette.com/2017/12/12/flossbach-von-storch-ag-sells-3150-shares-of-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.